COCRYSTAL PHARMA, INC. Cash
COCRYSTAL PHARMA, INC. (COCP) had Cash of $2.17 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-13
- 2026-06-30: Cash $2.17M.
- 2026-03-31: Cash $4.68M.
- 2025-12-31: Cash $7.03M.
- 2025-09-30: Cash $7.73M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $2.17M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.68M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $7.03M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $7.73M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $4.77M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $6.92M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $9.86M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $13.02M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $7.54M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $11.38M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $26.35M 10-K · filed 2025-03-31 | $16.33M 10-K · filed 2024-03-28 |
| 2023-09-30 | $29.74M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $32.42M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $33.98M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $37.14M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $58.70M 10-K · filed 2023-03-29 | |
| 2020-12-31 | $33.01M 10-K · filed 2021-03-17 | |
| 2020-09-30 | $31.78M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $19.32M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $21.69M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $7.42M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $5.99M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $7.47M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $8.57M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $2.72M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $4.68M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $6.84M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $1.25M 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $748.00K 10-K · filed 2020-03-27 | |
| 2017-09-30 | $1.34M 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |